Pulmonary Langerhans Cell Hysiocytosis: A Rare Pathology in The Practice of a Pulmonologist
https://doi.org/10.20514/2226-6704-2025-15-6-461-467
EDN: FNRNFA
Abstract
Pulmonary Langerhans cell histiocytosis is a rare disease with insidious onset and nonspecific manifestations. The article discusses two clinical cases of patients with a rare pathology — pulmonary histiocytosis from Langerhans cells. Young patients and smokers are described. The diagnosis was verified morphologically. In the first case, positive X–ray dynamics was noted against the background of smoking cessation, in the second case, the patient did not stop smoking, due to the severity of shortness of breath, changes in computed tomography of the lungs, prednisone was prescribed. Against this background, there was no significant positive trend.
About the Authors
E. S. Rvanina
Saratov State Medical University named after V.I. Razumovsky, Ministry of Health of the Russian Federation
Russian Federation
Competing Interests:
Russian Federation
Ekaterina S. Rvanina — resident of the 1st training, Department of Hospital Therapy, Faculty of Medicine
Saratov
Competing Interests:
The authors declare no conflict of interests
N. A. Karoli
Saratov State Medical University named after V.I. Razumovsky, Ministry of Health of the Russian Federation
Russian Federation
Competing Interests:
Russian Federation
Nina A. Karoli — professor of hospital therapy department of general medicine Department
Saratov
Competing Interests:
The authors declare no conflict of interests
References
1. Travis WD, Borok Z, Roum JH, et al. Pulmonary Langerhans cell granulomatosis (histiocytosis X). A clinicopathologic study of 48 cases. Am J Surg Pathol 1993; 17: 971–986
2. Mogulkoc N, Veral A, Bishop PW et al. Pulmonary Langerhans’ cell histiocytosis: radiologic resolution following smoking cessation. Chest. 1999; 115: 1452–1455
3. Vassallo R, Ryu JH, Schroeder DR et al. Clinical outcomes of pulmonary Langerhans’-cell histiocytosis in adults. N Engl J Med. 2002; 346: 484–490
4. Lorillon G, Tazi A. How I manage pulmonary Langerhans cell histiocytosis. Eur Respir Rev. 2017; 26: 170070 https://doi.org/10.1183/16000617.0070-2017.
5. Wei P., Lu H.W., Jiang S. et al. Pulmonary Langerhans cell histiocytosis: case series and literature review. Medicine (Baltimore). 2014; 93(23):e141. DOI: 10.1097/MD.0000000000000141
6. Potapenko v. G., Baykov v. v., Zinchenko A. et al. Langerhans cell histiocytosis in adults: literature review. Onkogematologiya = Oncohematology 2022;17(4):16–32. [In Russian]. DOI: 10.17650/1818-8346-2022-17-4-16-32
7. Roden A.C., Hu X., Kip S. et al. BRAF V600E expression in Langerhans cell histiocytosis: clinical and immunohistochemical study on 25 pulmonary and 54 extrapulmonary cases. Am J Surg Pathol 2014;38(4):548–51. DOI: 10.1097/PAS.0000000000000129
8. Girschikofsky M., Arico M., Castillo D. et al. Management of adult patients with Langerhans cell histiocytosis: recommendations from an expert panel on behalf of EuroHistioNet. Orphanet J Rare Dis 2013;(8):72. DOI: 10.1186/17501172872
9. Sawalha L., Kumar A., Arshad A. et al. Pulmonary Langerhans cell histiocytosis: radiologic resolution following cessation of second-hand smoking. Clin Respir J. 2017;11(6):1063–7. DOI: 10.1111/crj.12445
10. Delobbe A., Durieu J., Duhamel A. et al. Determinants of survival in pulmonary Langerhans’ cell granulomatosis (histiocytosis X). Groupe d’Etude en Pathologie Interstitielle de la Société de Pathologie Thoracique du Nord. Eur Respir J. 1996;9(10):2002–6. DOI: 10.1183/09031936.96.09102002
Review
For citations:
Rvanina E.S., Karoli N.A. Pulmonary Langerhans Cell Hysiocytosis: A Rare Pathology in The Practice of a Pulmonologist. The Russian Archives of Internal Medicine. 2025;15(6):461-467. (In Russ.) https://doi.org/10.20514/2226-6704-2025-15-6-461-467. EDN: FNRNFA
Views:
142
JATS XML
Email this article 